Specialties
Fracture
Specialties
Knee
Specialties
Regenerative Medicine
655 results found in 11ms
ChondroFiller NHS status and private access routesChondroFiller NHS status and private access routes
ChondroFiller is not available on the NHS, pending formal health technology assessment; private, self-funded treatment is the sole current UK access route.ChondroFiller is not available on the NHS, pending formal health technology assessment; private, self-funded treatment is the sole current UK access route.
ChondroFiller for TMJ cartilage defectsChondroFiller for TMJ cartilage defects
ChondroFiller, an injectable collagen scaffold that recruits cartilage-forming cells, shows functional improvements in small-joint cartilage structurally similar to the TMJ, but remains an emerging, untested application for the jaw.ChondroFiller, an injectable collagen scaffold that recruits cartilage-forming cells, shows functional improvements in small-joint cartilage structurally similar to the TMJ, but remains an emerging, untested application for the jaw.
What IKDC and MOCART scores mean after ChondroFillerWhat IKDC and MOCART scores mean after ChondroFiller
IKDC scores typically improve by about 30 points after ChondroFiller—roughly double the clinically meaningful threshold—translating to pain-free walking, stair management, and low-moderate recreational return within a year.IKDC scores typically improve by about 30 points after ChondroFiller—roughly double the clinically meaningful threshold—translating to pain-free walking, stair management, and low-moderate recreational return within a year.
ChondroFiller injection for ankle cartilage defectsChondroFiller injection for ankle cartilage defects
ChondroFiller is an acellular collagen scaffold that fills talar cartilage defects without tissue harvest or surgery: it gels within the lesion and recruits the patient's own progenitor cells to drive repair. Delivered under ultrasound guidance as an outpatient procedure, it requires no general anaesthetic or theatre admission.ChondroFiller is an acellular collagen scaffold that fills talar cartilage defects without tissue harvest or surgery: it gels within the lesion and recruits the patient's own progenitor cells to drive repair. Delivered under ultrasound guidance as an outpatient procedure, it requires no general anaesthetic or theatre admission.
ChondroFiller for focal knee defects versus early osteoarthritisChondroFiller for focal knee defects versus early osteoarthritis
Focal cartilage defects and early osteoarthritis produce identical symptoms but differ structurally — a contained lesion versus compartment-wide degeneration — and imaging determines which pathway applies. ChondroFiller, an injectable collagen scaffold into which the body's progenitor cells migrate and lay down new cartilage tissue, addresses only focal lesions.Focal cartilage defects and early osteoarthritis produce identical symptoms but differ structurally — a contained lesion versus compartment-wide degeneration — and imaging determines which pathway applies. ChondroFiller, an injectable collagen scaffold into which the body's progenitor cells migrate and lay down new cartilage tissue, addresses only focal lesions.
Choosing a ChondroFiller injection providerChoosing a ChondroFiller injection provider
ChondroFiller's collagen scaffold gels within minutes; accurate positioning demands real-time ultrasound guidance, and candidacy assessment requires pre-treatment MRI review.ChondroFiller's collagen scaffold gels within minutes; accurate positioning demands real-time ultrasound guidance, and candidacy assessment requires pre-treatment MRI review.
Who qualifies for ChondroFiller Liquid Cartilage injectionWho qualifies for ChondroFiller Liquid Cartilage injection
ChondroFiller is an outpatient ultrasound-guided injection—not surgery—of acellular collagen that recruits the patient's own progenitor cells to regenerate cartilage damage, without upper age or defect-size limits.ChondroFiller is an outpatient ultrasound-guided injection—not surgery—of acellular collagen that recruits the patient's own progenitor cells to regenerate cartilage damage, without upper age or defect-size limits.
ChondroFiller injection costs in the UK and EuropeChondroFiller injection costs in the UK and Europe
ChondroFiller costs £3,000–£8,000 in the UK, scaled by defect size, delivered as an ultrasound-guided outpatient injection with no surgery or anaesthetic.ChondroFiller costs £3,000–£8,000 in the UK, scaled by defect size, delivered as an ultrasound-guided outpatient injection with no surgery or anaesthetic.
ChondroFiller for Shoulder Cartilage DefectsChondroFiller for Shoulder Cartilage Defects
Focal shoulder cartilage defects are now treatable with a single ultrasound-guided collagen injection that recruits the body's own repair cells, forming hyaline-like tissue over 12 months without surgery or general anaesthetic.Focal shoulder cartilage defects are now treatable with a single ultrasound-guided collagen injection that recruits the body's own repair cells, forming hyaline-like tissue over 12 months without surgery or general anaesthetic.
Recovery after a ChondroFiller injectionRecovery after a ChondroFiller injection
ChondroFiller works by recruiting the body's progenitor cells into a collagen scaffold to regenerate cartilage; improvement takes six to twelve weeks, not days.ChondroFiller works by recruiting the body's progenitor cells into a collagen scaffold to regenerate cartilage; improvement takes six to twelve weeks, not days.
ChondroFiller injection safety: what the evidence showsChondroFiller injection safety: what the evidence shows
Over 19,000 ChondroFiller injections have been administered globally with no serious adverse effects reported; reoperation rates of 3–8% fall well below surgical alternatives such as microfracture (up to 41%) and ACI/MACI (up to 37%).Over 19,000 ChondroFiller injections have been administered globally with no serious adverse effects reported; reoperation rates of 3–8% fall well below surgical alternatives such as microfracture (up to 41%) and ACI/MACI (up to 37%).
What ChondroFiller's CE approval means for UK patientsWhat ChondroFiller's CE approval means for UK patients
ChondroFiller recruits the body's progenitor cells to repair focal cartilage defects, achieving symptom relief in 70–85% of selected patients, though it offers no benefit for widespread osteoarthritis.ChondroFiller recruits the body's progenitor cells to repair focal cartilage defects, achieving symptom relief in 70–85% of selected patients, though it offers no benefit for widespread osteoarthritis.
655 results found in 11ms